
Inhibidores
Los inhibidores son moléculas que se unen a enzimas, receptores u otras proteínas para reducir o bloquear su actividad biológica. Estos compuestos se utilizan ampliamente en la investigación para estudiar vías biológicas, comprender los mecanismos de las enfermedades y desarrollar fármacos terapéuticos. Los inhibidores desempeñan un papel crucial en el tratamiento de diversas enfermedades, incluyendo el cáncer, las enfermedades cardiovasculares y las infecciones. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad para apoyar su investigación en bioquímica, biología celular y desarrollo farmacéutico.
Subcategorías de "Inhibidores"
- Angiogénesis(2.519 productos)
- Apoptosis(5.787 productos)
- Ciclo celular / Checkpoint(4.446 productos)
- Cromatina / Epigenética(2.235 productos)
- Señalización citoesquelética(1.381 productos)
- Daño al ADN / Reparación del ADN(2.824 productos)
- Endocrinología / Hormonas(3.500 productos)
- Enzima(3.639 productos)
- GPCR / proteína G(8.317 productos)
- Inmunología e inflamación(3.516 productos)
- Virus de la gripe(296 productos)
- Señalización JAK / STAT(404 productos)
- Señalización MAPK(1.200 productos)
- Transportador de membrana / canal de iones(2.787 productos)
- Metabolismo(9.416 productos)
- Microbiología / Virología(6.968 productos)
- Neurociencia(9.919 productos)
- Otros inhibidores(37.928 productos)
- Reducción de oxidación(41 productos)
- Señalización PI3K / Akt / mTOR(1.400 productos)
- Proteasas / Proteasoma(1.596 productos)
- Células madre y Derivados(831 productos)
- Tirosina quinasa / adaptadores(2.015 productos)
- Ubiquitinación(1.649 productos)
Mostrar 16 subcategorías más
Se han encontrado 66626 productos de "Inhibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
JAK-IN-34
CAS:<p>JAK-IN-34 (compound 11n) is a potent inhibitor of Janus kinases (JAKs), demonstrating IC50 values of 0.40 nM for JAK1, 0.83 nM for JAK2, 2.10 nM for JAK3,</p>Fórmula:C27H26N6OPureza:98%Forma y color:SolidPeso molecular:450.53BTK-IN-25
CAS:<p>BTK-IN-25 (compound 71) is a potent BTK inhibitor, demonstrating an IC50 of 0.77 nM against BTK(C481S) and achieving an IC50 of 1 nM in DOHH2 cells [1].</p>Fórmula:C28H27F2N3O5Pureza:98%Forma y color:SolidPeso molecular:523.53BET-IN-14
CAS:<p>BET-IN-14 is a pan BET inhibitor with an IC50 of 5.35 nM, demonstrating oral activity and anticancer properties [1].</p>Fórmula:C30H37N7O2Pureza:98%Forma y color:SolidPeso molecular:527.66Xilmenolone
CAS:<p>Xilmenolone acts as a positive allosteric modulator of the GABA_A receptor [1].</p>Fórmula:C26H37N3O2Pureza:98%Forma y color:SolidPeso molecular:423.59Ref: TM-T78670
Producto descatalogadoLerzeparib
CAS:<p>Lerzeparib is a PARP (ADP-ribose polymerase) inhibitor that exhibits antineoplastic activity [1].</p>Fórmula:C21H20FN3O2Pureza:98%Forma y color:SolidPeso molecular:365.4LFS-1107
CAS:<p>LFS-1107, a reversible CRM1 inhibitor (Kd: 12.5 pM), selectively targets and eliminates ENKTL cells, offering potential for cancer research applications [1].</p>Fórmula:C12H11N5OS2Pureza:98%Forma y color:SolidPeso molecular:305.38Antitumor photosensitizer-2
CAS:<p>Compound 11, also known as Antitumor Photosensitizer-2, is a potent photosensitizer with remarkable photodynamic anti-tumor properties and minimal skin photo-</p>Fórmula:C40H47N5O7Forma y color:SolidPeso molecular:709.83JDB175
CAS:<p>JDB175, a selective BTK inhibitor with oral bioavailability, demonstrates excellent penetration through the blood-brain barrier.</p>Fórmula:C26H21F3N4O2Pureza:98%Forma y color:SolidPeso molecular:478.47EST73502
CAS:<p>EST73502 is a compound that functions as a dual agonist for the μ-opioid receptor (MOR) and an antagonist for the σ1 receptor (σ1R). It is selective, orally active, and possesses the ability to penetrate the blood-brain barrier (BBB). The compound exhibits a Ki value of 64 nM for the MOR and 118 nM for the σ1R. Additionally, EST73502 demonstrates antinociceptive activity [1].</p>Fórmula:C19H26F2N2O2Pureza:98%Forma y color:SolidPeso molecular:352.426CYY292
CAS:<p>CYY292 is a chemical compound acting as an inhibitor of PDGFRα, PDGFRβ, FGFR1, -2, and -3, with respective IC50 values of 5.35, 4.6, 28, 28, and 78 nM.</p>Fórmula:C24H28N8OForma y color:SolidPeso molecular:444.53JAK1-IN-11
CAS:<p>JAK1-IN-11 (compound 11) serves as a potent inhibitor of Janus kinases, exhibiting nanomolar inhibitory concentrations with IC50 values of 0.02 nM (JAK1) and 0.</p>Fórmula:C26H36N6O4SPureza:98%Forma y color:SolidPeso molecular:528.67URAT1&XO inhibitor 1
CAS:<p>URAT1&XO Inhibitor 1 (compound 29) serves as a dual inhibitor with IC50 values of approximately 10 μM for URAT1 and 1.01 μM for Xanthine Oxidase.</p>Fórmula:C20H13N5O3SPureza:98%Forma y color:SolidPeso molecular:403.41Ref: TM-T79175
Producto descatalogadoEstrogen receptor modulator 8
CAS:<p>Estrogen Receptor Modulator 8 (compound 4) is an orally active inhibitor targeting Estrogen Receptor/ERR α with potent efficacy (IC50 = 0.437 nM in MCF-7 cells</p>Fórmula:C25H24F4N2O2Pureza:98%Forma y color:SolidPeso molecular:460.46Anti-MI/R injury agent 1
CAS:<p>Anti-MI/R injury agent 1 (compound 18), derived from Panaxatriol, represents an orally administered, potent agent against myocardial ischemia/reperfusion (MI/R</p>Fórmula:C32H49NO6Forma y color:SolidPeso molecular:543.73Tauro-Obeticholic Acid sodium
CAS:<p>Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid.</p>Fórmula:C28H48NO6S·NaForma y color:SolidPeso molecular:549.74Cap-dependent endonuclease-IN-9
CAS:<p>Cap-dependent endonuclease-IN-9, a strong influenza inhibitor, shows low toxicity, good pharmacokinetics, and dynamic action.</p>Fórmula:C29H22F2N4O7SPureza:98%Forma y color:SolidPeso molecular:608.57Ref: TM-T72125
Producto descatalogadoPHI-101
CAS:<p>PHI-101 is a checkpoint kinase 2 (Chk2) inhibitor that can be used for the study of refractory acute myeloid leukemia (AML) and ovarian cancer.</p>Fórmula:C19H19FN4O2SPureza:99.4%Forma y color:SolidPeso molecular:386.44ALS-I-41
CAS:<p>ALS-I-41 is a novel, potent and selective antagonist of oxytocin receptor.</p>Fórmula:C30H38FN3O6SPureza:98%Forma y color:SolidPeso molecular:587.7BPH-628
CAS:<p>BPH-628 is a bioactive chemical.</p>Fórmula:C20H20O7P2Forma y color:SolidPeso molecular:434.32hDHODH-IN-8
<p>hDHODH-IN-8 is a potent human dihydroorotic dehydrogenase (hDHODH) inhibitor (IC50: 16 nM) that exhibits potent antiproliferative effects and has good water solubility, with potential for oncology studies, especially in lymphoma.</p>Fórmula:C21H15F6N3O4Pureza:98%Peso molecular:487.35Ifetroban sodium
CAS:<p>Ifetroban sodium (BMS-180291), oral TXA2/PGH2 antagonist for researching heart, stroke, BP, thrombosis.</p>Fórmula:C25H31N2NaO5Forma y color:SolidPeso molecular:462.522Ifetroban
CAS:<p>Ifetroban is a potent and selective TxA2/PGH2 receptor antagonist.</p>Fórmula:C25H32N2O5Forma y color:SolidPeso molecular:440.53Dimethandrolone Undecanoate
CAS:<p>Dimethandrolone Undecanoate (DMAU) is a novel orally available androgen with progestational activity and is a potential male contraceptive compound.</p>Fórmula:C31H50O3Pureza:99.65% - >99.99%Forma y color:SolidPeso molecular:470.73Ref: TM-T27176
Producto descatalogadoDG026
CAS:<p>DG026 selectively inhibits IRAP, reducing its cross-presentation in dendritic cells without affecting ERAP1.</p>Fórmula:C35H40N3O4PPureza:98%Forma y color:SolidPeso molecular:597.68Cortivazol
CAS:<p>Cortivazol is an Anti-Inflammatory Drug.</p>Fórmula:C32H38N2O5Pureza:98%Forma y color:SolidPeso molecular:530.65Ref: TM-T25271
Producto descatalogadoROCK-IN-6
CAS:<p>ROCK-IN-6, a selective ROCK2 inhibitor, exhibits potent inhibition with an IC50 of 2.19 nM and holds promise for research into glaucoma and retinal diseases [1</p>Fórmula:C19H19N5O8SPureza:98%Forma y color:SolidPeso molecular:477.45Ref: TM-T79077
Producto descatalogado

